Canostix is developing a blood-based cancer test that combines photonics and machine learning, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines.
Business ModelSaaS (applied IT)
- Life Science & Healthcare
Top 10 out of more than 900 start-ups at the TATA Social Enterprise Challange 2019.
BAFA - INVEST - Zuschuss für Wagniskapital
Investmentbank Berlin - Gründungsbonus
Brandenburgische Straße 10